Effects of P-Mapa Associated With Gemcitabine in the Pancreatic Cancer: Histologic Effects

doi 10.19146/pibic-2016-51054
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Galoa

Related search

Microarray Analysis of Circular RNA Expression Profiles Associated With Gemcitabine Resistance in Pancreatic Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2018English

Differences in Survival by Histologic Type of Pancreatic Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2005English

Galunisertib Plus Gemcitabine vs. Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Multi-Scale Network Model Supported by Proteomics for Analysis of Combined Gemcitabine and Birinapant Effects in Pancreatic Cancer Cells

CPT: Pharmacometrics and Systems Pharmacology
ModelingSimulationCardiovascular MedicinePharmacologyCardiology
2018English

Timing of Chemotherapy-Induced Neutropenia: The Prognostic Factor in Advanced Pancreatic Cancer Patients Treated With Gemcitabine / Gemcitabine-Based Chemotherapy

Oncotarget
Oncology
2017English

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

Establishment and Characterization of the Gemcitabine‑resistant Human Pancreatic Cancer Cell Line SW1990/gemcitabine

Oncology Letters
Cancer ResearchOncology
2019English

Inhibitory Effect of Baicalein Combined With Gemcitabine in Human Pancreatic Cancer Cell Lines

Oncology Letters
Cancer ResearchOncology
2018English

Interaction Between Cancer Associated Fibroblasts (CAFs) and Cancer Cells in Pancreatic Cancer – Effects on Therapy Response and Migration

HPB
HepatologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy